SE389739B - Sett att pavisa opiumalkaloider - Google Patents

Sett att pavisa opiumalkaloider

Info

Publication number
SE389739B
SE389739B SE7408141A SE814174A SE389739B SE 389739 B SE389739 B SE 389739B SE 7408141 A SE7408141 A SE 7408141A SE 814174 A SE814174 A SE 814174A SE 389739 B SE389739 B SE 389739B
Authority
SE
Sweden
Prior art keywords
way
opium alkaloids
opium
alkaloids
provide opium
Prior art date
Application number
SE7408141A
Other languages
English (en)
Inventor
S Spector
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE389739B publication Critical patent/SE389739B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SE7408141A 1970-05-13 1971-05-13 Sett att pavisa opiumalkaloider SE389739B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3699970A 1970-05-13 1970-05-13

Publications (1)

Publication Number Publication Date
SE389739B true SE389739B (sv) 1976-11-15

Family

ID=21891894

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7408141A SE389739B (sv) 1970-05-13 1971-05-13 Sett att pavisa opiumalkaloider
SE7106271A SE389737B (sv) 1970-05-13 1971-05-13 Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset
SE7408140A SE417970B (sv) 1970-05-13 1974-06-19 Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska
SE7408141A SE7408141L (sv) 1970-05-13 1974-06-19

Family Applications After (3)

Application Number Title Priority Date Filing Date
SE7106271A SE389737B (sv) 1970-05-13 1971-05-13 Reagens for bestemning av opiumalkaloider innefattande en opiumalkaloidspecifik antikropp jemte sett att framstella reagenset
SE7408140A SE417970B (sv) 1970-05-13 1974-06-19 Opiumalkaloidantigen till anvendning vid framstellning av en antikropp som kan utnyttjas vid immunanalys av opiumalkaloiden i biologisk vetska
SE7408141A SE7408141L (sv) 1970-05-13 1974-06-19

Country Status (5)

Country Link
CA (1) CA966778A (sv)
DE (1) DE2166716C3 (sv)
DK (1) DK142145B (sv)
GB (1) GB1320056A (sv)
SE (4) SE389739B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
CN113968853B (zh) * 2020-07-22 2022-09-16 中国农业大学 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用

Also Published As

Publication number Publication date
DE2166716C3 (de) 1980-06-12
SE7408141L (sv) 1974-06-19
SE417970B (sv) 1981-04-27
CA966778A (en) 1975-04-29
SE7408140L (sv) 1974-06-19
DK142145C (sv) 1981-02-02
DE2166716A1 (de) 1975-04-24
GB1320056A (en) 1973-06-13
DE2166716B2 (de) 1979-09-27
DE2123300B2 (de) 1976-03-04
DK142145B (da) 1980-09-08
SE389737B (sv) 1976-11-15
DE2123300A1 (de) 1971-11-25

Similar Documents

Publication Publication Date Title
FI56018B (fi) Foerfarande foer framstaellning av 5-azapyrimidinnukleosider
BE763072R (fr) Perfectionnements aux
FI55686C (fi) Foerfarande foer framstaellning av blanka vaermebestaendiga polyamidimidfibrer
SE393383B (sv) Sett att framstella adenosinderivat
SE412586B (sv) Sett att framstella isoflavonderivat
BR7103903D0 (pt) Estrutura de panela
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE7901914L (sv) Sett att tillverka samlingsperm
SE8205332D0 (sv) Sett att framstella hoghallfast stalband
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
TR17768A (tr) Uere tuerevleri
SE391337B (sv) Sett att framstella 2-substituerade adenosinderivat
SE384867B (sv) Sett att framstella 2-substituerade adenosinderivat
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE389116B (sv) Sett att syntetisera pteridiner
SE397679B (sv) Sett att framstella kinazolinonderivat
SE389739B (sv) Sett att pavisa opiumalkaloider
SE373570B (sv) Sett att framstella halogenerade styren-halocyklopentadienaddukter
SE415884B (sv) Sett att framstella vinkamon
SE390301B (sv) Sett att framstella butyrfenonederivat
BE773090A (fr) Penicillines
SE390308B (sv) Sett att framstella substituerade kobamider

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7408141-5

Effective date: 19900518

Format of ref document f/p: F